Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...
The S&P 500 won't pull back next year as the market enters the third year of a cyclical bull run, Brian Belski said.
Brian Belski, chief investment strategist at BMO Capital Markets, joins 'Halftime Report' to lay out his case for his firm's ...
TJX Cos raised its annual profit forecast on Wednesday, benefiting from lower costs and strong demand from cash-strapped ...
Salesforce (NYSE:CRM – Free Report) had its price target upped by BMO Capital Markets from $305.00 to $385.00 in a research ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.50% of ...
Stocks are taking a breather after a big, post-election run. But behind the broad market action are plenty of interesting ...
Goldman Sachs sees the S&P 500 gaining 11% over the next year as stock market gains continue to broaden out from a few large ...
BMO Capital notes that Silence Therapeutics (SLN) is trading significantly lower following AHA updates due to concerns that favorable data from oral Muvalaplin may potentially be a competitive threat ...
BMO Capital Markets upgraded Independence Realty Trust (NYSE:IRT) stock to Market Perform from Underperform as rents in the ...
The stock market rally takes a breather. Now it’s at the mercy of the bond market as investors weigh Donald Trump’s economic ...